At Harris Health System, we champion better health for our patients, their families and our community, by connecting all to an integrated healthcare system that provides high-quality healthcare.
Harris Health System focuses on the delivery of primary care, wellness and prevention services to the residents of Harris County, Texas, through its extensive network of 48 inpatient and outpatient facilities.
Harris Health is staffed by physician faculty and residents from nationally ranked medical schools, Baylor College of Medicine, McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth) and M.D. Anderson Cancer Center.
Mission
Harris Health is a community-focused academic healthcare system dedicated to improving the health of those most in need in Harris County through quality care delivery, coordination of care, and education.
Vision
Harris Health will become the premier public academic healthcare system in the nation.
We Value
Quality and Patient Safety
United as One
Accountable and Just Culture
Leadership and Integrity
Innovation, Education, Research
Trust, Recognition, Respect
You: Patients, Employees, Medical Staff
VOLUME STATISTICS - FY 2021
Cases occupying beds – 36,481
Births – 4,217
Emergency visits – 132,514
Outpatient clinic visits – 1,403,263
For more information on Harris Health System, visit harrishealth.org
Neurocrine Biosciences is a leading biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs. We are dedicated to discovering, developing and commercializing life-changing treatments for patients with under-addressed neurological, psychiatric, endocrine and immunological disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, hyperphagia in patients with Prader-Willi syndrome, endometriosis* and uterine fibroids,* as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. For three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders because you deserve brave science.
Review our Community Guidelines: https://bit.ly/NeurocrineLinkedInGuidelines
*in collaboration with AbbVie
Neuronetics, Inc., is the creator of NeuroStar Advanced Therapy, the market leader in Transcranial Magnetic Stimulation (TMS) for the treatment of Major Depressive Disorder. Based in Malvern, PA, we are a public medical device company (STIM) with a strategic vision of transforming the lives of patients whenever and wherever they need it with the best neurohealth therapies in the world.
NeuroStar is the #1 TMS choice of doctors, with over 4.3 million treatments performed to date. It is an advanced treatment for depression. It is not medication, shock therapy, or surgery. NeuroStar is an outpatient treatment done in as little as 20 minutes for 36 sessions. It promotes neuroplasticity to target depression where it starts — the brain.
Neuronetics markets NeuroStar Advanced Therapy throughout the United States and select markets around the world.
If you have questions or comments about NeuroStar, please e-mail us at customersupport@neurostar.com. For U.S. phone support, please call us at (877) 600-7555, for international customers, our number is +1 (610) 640-4207.
Please visit NeuroStar.com/Safety for full safety and prescribing information.